down arrow

Zenith Health

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE812B01026
  • NSEID:
  • BSEID: 530665
INR
4.76
-0.09 (-1.86%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 24.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

24.11 k (-61.98%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.39%

Held by 0 DIIs

Promoter

28.74%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.12
  • The company has been able to generate a Return on Equity (avg) of 5.80% signifying low profitability per unit of shareholders funds
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 26 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

-4.35%

stock-summary
Price to Book

3.44

Revenue and Profits (1 Year):
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-11.69%
0%
-11.69%
1 Year
1.06%
0%
1.06%
2 Years
12.26%
0%
12.26%
3 Years
-35.33%
0%
-35.33%
4 Years
-22.22%
0%
-22.22%
5 Years
328.83%
0%
328.83%

Zenith Health for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.63%
EBIT Growth (5y)
-9.41%
EBIT to Interest (avg)
0.12
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.75
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
2.11%
ROE (avg)
5.80%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
3.44
EV to EBIT
-23.43
EV to EBITDA
-23.43
EV to Capital Employed
4.73
EV to Sales
2.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.81%
ROE (Latest)
-4.35%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.39%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Mahendra Chatrabhuj Raycha (12.29%)

Highest Public shareholder

Sharpline Trading Co. Pvt. Ltd. (3.29%)

Individual Investors Holdings

64.16%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -23.76% vs 17.90% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -422.22% vs -43.75% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.31",
          "val2": "3.03",
          "chgp": "-23.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.19",
          "val2": "0.15",
          "chgp": "-226.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.29",
          "val2": "0.09",
          "chgp": "-422.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.23%",
          "val2": "4.95%",
          "chgp": "-13.18%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -25.43% vs -3.96% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -30.56% vs 80.00% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.60",
          "val2": "7.51",
          "chgp": "-25.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.26",
          "val2": "0.48",
          "chgp": "-45.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.25",
          "val2": "0.36",
          "chgp": "-30.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.64%",
          "val2": "6.39%",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -30.61% vs -0.70% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -108.70% vs 53.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.91",
          "val2": "11.40",
          "chgp": "-30.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.07",
          "val2": "0.63",
          "chgp": "-88.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.02",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.04",
          "val2": "0.46",
          "chgp": "-108.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.88%",
          "val2": "5.45%",
          "chgp": "-4.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.21% vs -41.28% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 150.00% vs -74.19% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.47",
          "val2": "13.13",
          "chgp": "10.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.23",
          "val2": "0.03",
          "chgp": "666.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.20",
          "val2": "0.08",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.59%",
          "val2": "0.23%",
          "chgp": "1.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2.31
3.03
-23.76%
Operating Profit (PBDIT) excl Other Income
-0.19
0.15
-226.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.29
0.09
-422.22%
Operating Profit Margin (Excl OI)
-8.23%
4.95%
-13.18%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -23.76% vs 17.90% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -422.22% vs -43.75% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
5.60
7.51
-25.43%
Operating Profit (PBDIT) excl Other Income
0.26
0.48
-45.83%
Interest
0.01
0.01
Exceptional Items
0.00
0.00
Standalone Net Profit
0.25
0.36
-30.56%
Operating Profit Margin (Excl OI)
4.64%
6.39%
-1.75%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -25.43% vs -3.96% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -30.56% vs 80.00% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
7.91
11.40
-30.61%
Operating Profit (PBDIT) excl Other Income
0.07
0.63
-88.89%
Interest
0.01
0.02
-50.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.04
0.46
-108.70%
Operating Profit Margin (Excl OI)
0.88%
5.45%
-4.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -30.61% vs -0.70% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -108.70% vs 53.33% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
14.47
13.13
10.21%
Operating Profit (PBDIT) excl Other Income
0.23
0.03
666.67%
Interest
0.01
0.01
Exceptional Items
0.00
0.00
Standalone Net Profit
0.20
0.08
150.00%
Operating Profit Margin (Excl OI)
1.59%
0.23%
1.36%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.21% vs -41.28% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 150.00% vs -74.19% in Mar 2023

stock-summaryCompany CV
About Zenith Health Care Ltd stock-summary
stock-summary
Zenith Health Care Ltd
Micro Cap
Pharmaceuticals & Drugs
Zenith Healthcare Limited, incorporated in 1994, is an ISO 9001:2008 & WHO-cGMP certified company, which is strategically located in Changodar, from Ahmedabad International Airport and 20 Km from the main city of Ahmedabad in Gujarat which is the hub of Indian Pharmaceutical Industry. The Company is engaged into manufacturing of tablets, capsules, ointments, and liquid injectable among others.
Company Coordinates stock-summary
Company Details
504 Iscon Elegance S G Road, Nr Ananddham Jain Derasar Ahmedabad Gujarat : 380051
stock-summary
Tel: 91-79-66168889/66168890
stock-summary
mahendrazenith@hotmail.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai